Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · January 06, 2022

CNS Involvement in AML at Diagnosis Is Rare and Does Not Affect Response or Survival

Blood Advances


Additional Info

Blood Advances
CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials
Blood Adv 2021 Nov 23;5(22)4560-4568, C Ganzel, JW Lee, HF Fernandez, EM Paietta, SM Luger, HM Lazarus, LD Cripe, D Douer, PH Wiernik, JM Rowe, MS Tallman, MR Litzow

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Brain Cancer Center of Excellence

Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.

Further Reading